Cargando…

Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer

The roles of non-coding RNAs in controlling clinical and biological heterogeneity in bladder cancer remain unclear. We used TCGA's published dataset (n = 405 tumors) as a discovery cohort and created a new validation cohort to define the miRNA expression patterns in the basal and luminal molecu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ochoa, Andrea E., Choi, Woonyoung, Su, Xiaoping, Siefker-Radtke, Arlene, Czerniak, Bogdan, Dinney, Colin, McConkey, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Priority Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348311/ https://www.ncbi.nlm.nih.gov/pubmed/27845906 http://dx.doi.org/10.18632/oncotarget.13284

Ejemplares similares

Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use
por: Dadhania, Vipulkumar, et al.
Publicado: (2016)

Intrinsic subtypes and bladder cancer metastasis
por: McConkey, David J., et al.
Publicado: (2016)

Inhibition of Inducible Heat Shock Protein-70 (Hsp72) Enhances Bortezomib-Induced Cell Death in Human Bladder Cancer Cells
por: Qi, Wei, et al.
Publicado: (2013)

Assessment of Luminal and Basal Phenotypes in Bladder Cancer
por: Guo, Charles C., et al.
Publicado: (2020)

p63 Expression Defines a Lethal Subset of Muscle-Invasive Bladder Cancers
por: Choi, Woonyoung, et al.
Publicado: (2012)

Update on bladder cancer molecular subtypes
por: Fong, Megan Hoi Yan, et al.
Publicado: (2020)

Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis
por: Roth, Beat, et al.
Publicado: (2016)

Fibroblast Growth Factor Receptors-1 and -3 Play Distinct Roles in the Regulation of Bladder Cancer Growth and Metastasis: Implications for Therapeutic Targeting
por: Cheng, Tiewei, et al.
Publicado: (2013)

Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer
por: Yang, Guoliang, et al.
Publicado: (2020)

MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cells
por: Sánchez-Cid, Lourdes, et al.
Publicado: (2017)

RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation
por: Yang, Jianqi, et al.
Publicado: (2016)

Combined use of immunohistochemical markers of basal and luminal subtypes in urothelial carcinoma of the bladder: Association with clinicopathological features and outcomes
por: Ravanini, Juliana Naves, et al.
Publicado: (2021)

In-Frame cDNA Library Combined with Protein Complementation Assay Identifies ARL11-Binding Partners
por: Lee, Sangkyou, et al.
Publicado: (2012)

Integrative Transcriptomic, Lipidomic, and Metabolomic Analysis Reveals Potential Biomarkers of Basal and Luminal Muscle Invasive Bladder Cancer Subtypes
por: Feng, Chao, et al.
Publicado: (2021)

Autophagy is required for crizotinib-induced apoptosis in MET-amplified gastric cancer cells
por: Schroeder, Rebecca D., et al.
Publicado: (2017)

Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples
por: Opota, Onya, et al.
Publicado: (2020)

Erdafitinib for locally advanced or metastatic urothelial carcinoma
por: Siefker-Radtke, Arlene O, et al.
Publicado: (2022)

Detection of Bladder Cancer Using Proteomic Profiling of Urine Sediments
por: Majewski, Tadeusz, et al.
Publicado: (2012)

Unique somatic variants in DNA from urine exosomes of individuals with bladder cancer
por: Zhou, Xunian, et al.
Publicado: (2021)

Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas
por: Cryan, Jane B., et al.
Publicado: (2014)

Inhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation
por: Plote, Devin, et al.
Publicado: (2019)

Naturally-occurring canine invasive urothelial carcinoma harbors luminal and basal transcriptional subtypes found in human muscle invasive bladder cancer
por: Dhawan, Deepika, et al.
Publicado: (2018)

Differential localization of glioblastoma subtype: implications on glioblastoma pathogenesis
por: Steed, Tyler C., et al.
Publicado: (2016)

The origin of bladder cancer from mucosal field effects
por: Bondaruk, Jolanta, et al.
Publicado: (2022)

The origin of bladder cancer from mucosal field effects
por: Bondaruk, Jolanta, et al.
Publicado: (2022)

Association between mammographic density and basal-like and luminal A breast cancer subtypes
por: Razzaghi, Hilda, et al.
Publicado: (2013)

c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression
por: Cantrell, Michael A., et al.
Publicado: (2015)

Lentiviral interferon: A novel method for gene therapy in bladder cancer
por: Mokkapati, Sharada, et al.
Publicado: (2022)

Comparative Gene Expression Analyses Identify Luminal and Basal Subtypes of Canine Invasive Urothelial Carcinoma That Mimic Patterns in Human Invasive Bladder Cancer
por: Dhawan, Deepika, et al.
Publicado: (2015)

Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer: A cross-sectional study
por: Oshiro, Hisashi, et al.
Publicado: (2016)

Non-Muscle-Invasive Bladder Carcinoma with Respect to Basal Versus Luminal Keratin Expression
por: Jung, Minsun, et al.
Publicado: (2020)

Bladder Cancer Guidelines: Let Not the Cure Be Worse than the Disease
por: Kamat, Ashish M.
Publicado: (2021)

Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior
por: Mobley, Aaron, et al.
Publicado: (2017)

Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes
por: Messier, Terri L., et al.
Publicado: (2016)

The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtype
por: Bertucci, François, et al.
Publicado: (2020)

Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
por: van der Vos, K. E., et al.
Publicado: (2020)

“Bladder Effect” - An Urodynamic Parameter to Distinguish Subtypes of Urinary Incontinence in Women
por: Stojchevski, Sasho, et al.
Publicado: (2018)

MEK is a promising target in the basal subtype of bladder cancer
por: Merrill, Nathan M., et al.
Publicado: (2020)

Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder Cancers
por: Kim, Doris, et al.
Publicado: (2016)

microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers
por: Gasparini, Pierluigi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j26vuhs8m83ihflpbme83aids4